PRTK (update) PRTK has 3 PDUFA decisions during 10/18 Omadocycline would be the first once daily, multi-indicated oral antibiotic to be approved in 10 years. Its second antibiotic will be marketed by AGN and has a PDUFA later in October. Cash runway extends thru Q1/21 AdCom for Omadocycline will be 8/8/18